Guo D - Search Results

1

Chromatin Remodelling Molecule ARID1A Determines Metastatic Heterogeneity in Triple-Negative Breast Cancer by Competitively Binding to YAP.

Wang Y, Chen X, Qiao X, Xie Y, Guo D, Li B, Cao J, Tao Z, Hu X. Wang Y, et al. Among authors: guo d. Cancers (Basel). 2023 Apr 25;15(9):2447. doi: 10.3390/cancers15092447. Cancers (Basel). 2023. PMID: 37173914 Free PMC article.

2

A study of clinical and molecular characteristics in bilateral primary breast cancer.

Li B, Xu W, Cao J, Guo D, Tao Z, Jin J, Hu X. Li B, et al. Among authors: guo d. Cancer Med. 2023 Aug;12(15):15881-15892. doi: 10.1002/cam4.6226. Epub 2023 Jun 9. Cancer Med. 2023. PMID: 37293877 Free PMC article.

3

Immune Checkpoint Inhibitors Combined with Targeted Therapy: The Recent Advances and Future Potentials.

Li B, Jin J, Guo D, Tao Z, Hu X. Li B, et al. Among authors: guo d. Cancers (Basel). 2023 May 22;15(10):2858. doi: 10.3390/cancers15102858. Cancers (Basel). 2023. PMID: 37345194 Free PMC article. Review.

4

Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer.

Cao J, Yang M, Guo D, Tao Z, Hu X. Cao J, et al. Among authors: guo d. Cancer Med. 2024 Jul;13(14):e7472. doi: 10.1002/cam4.7472. Cancer Med. 2024. PMID: 39016065 Free PMC article. Review.

5

Chaperonin-containing TCP1 subunit 6A inhibition via TRIM21-mediated K48-linked ubiquitination suppresses triple-negative breast cancer progression through the AKT signalling pathway.

Yang M, Cao J, Liu T, Li B, Wang J, Pan S, Guo D, Tao Z, Hu X. Yang M, et al. Among authors: guo d. Clin Transl Med. 2024 Nov;14(11):e70097. doi: 10.1002/ctm2.70097. Clin Transl Med. 2024. PMID: 39556022 Free PMC article.

6

Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway.

Fei Q, Jin K, Shi S, Li T, Guo D, Lin M, Yu X, Wu W, Ye L. Fei Q, et al. Among authors: guo d. Acta Biochim Biophys Sin (Shanghai). 2024 Apr 25;56(4):513-524. doi: 10.3724/abbs.2023286. Acta Biochim Biophys Sin (Shanghai). 2024. PMID: 38229544 Free PMC article.

7

The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pancreatic cancer.

Shi S, Ye L, Jin K, Yu X, Guo D, Wu W. Shi S, et al. Among authors: guo d. Comput Struct Biotechnol J. 2024 Oct 5;23:3634-3650. doi: 10.1016/j.csbj.2024.09.032. eCollection 2024 Dec. Comput Struct Biotechnol J. 2024. PMID: 39469671 Free PMC article.

8

Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer.

Guo D, Ye L, Wu W, Yu X, Jin K. Guo D, et al. Acta Biochim Biophys Sin (Shanghai). 2023 Apr 6;55(6):923-937. doi: 10.3724/abbs.2023045. Acta Biochim Biophys Sin (Shanghai). 2023. PMID: 37021976 Free PMC article. Review.

9

The role of amino acid metabolism alterations in acute ischemic stroke: From mechanism to application.

Wang XP, Yan D, Jin XP, Zhang WY, Shi T, Wang X, Song W, Xiong X, Guo D, Chen S. Wang XP, et al. Among authors: guo d. Pharmacol Res. 2024 Sep;207:107313. doi: 10.1016/j.phrs.2024.107313. Epub 2024 Jul 17. Pharmacol Res. 2024. PMID: 39025169 Free article. Review.

10

Heterochromatin Protein Activates the Amylase Expression Pathway and Its Application to Recombinant Protein Expression in Penicillium oxalicum.

Guo D, Zhao S, Chen J, Han S, Li Y, Chen Y, Hu S, Hu Y. Guo D, et al. Curr Microbiol. 2025 Jan 9;82(2):75. doi: 10.1007/s00284-024-04058-0. Curr Microbiol. 2025. PMID: 39786583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,863 results

Search Page

Filters